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AbstractVitamin D receptor, encoded by VDR gene, mediates vitamin D functions by not only regulating calcium metabolism and homeostasis but also in regulating immune response. Polymorphisms in VDR gene may 
increase the progression of human immunodeficiency virus (HIV) infection into acquired immunodeficiency 
syndrome (AIDS). This study aimed to explore the distribution of VDR polymorphisms among HIV sero-positive 
patients in West Java. A cross-sectional study was performed, recruiting 96 patients infected with HIV and VDR 
polymorphisms were analyzed. The genotype distributions of Bsm-I among HIV-infected patients were 2.2%, 
18.5%, and 79.3% for BB, Bb, and bb, respectively whereas the distributions of Apa-I were 54.4%, 38.9%, and 
6.7% for AA, Aa and aa, respectively. The frequency of VDR polymorphisms in Bsm-I among HIV-infected patients 
in West Java were considered high for b allele (88.6%), and in contrast for A allele in Apa-I that was 73.91%. 
Further studies involving healthy controls are needed to explore the VDR polymorphisms distribution in general 
population. Moreover, a cohort study, albeit challenging, is needed to further assess the association between VDR polymorphisms and the progression of HIV infection.
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Distribusi Polimorfisme gen VDR Bsm-I rs1544410 dan Apa-I rs7975232 
pada Pasien HIV/AIDS di Jawa Barat
AbstrakReseptor vitamin D yang dikode oleh gen VDR mempunyai peranan penting terhadap fungsi vitamin D; tidak hanya dalam regulasi metabolisme dan keseimbangan kalsium namun juga berperan dalam meregulasi respons 
imun. Polimorfisme pada gen VDR dapat meningkatkan perkembangan infeksi human immunodeficiency virus 
(HIV) menjadi acquired immunodeficiency syndrome (AIDS). Penelitian ini bertujuan mengetahui distribusi 
polimorfisme gen VDR pada pasien HIV di Jawa Barat. Penelitian ini melibatkan 96 pasien HIV dan dilakukan 
analisis polimorfisme gen VDR. Distribusi genotip Bsm-I pada pasien HIV di Jawa Barat adalah 2,2%, 18,5%, dan 
79,3% untuk BB, Bb, dan bb, secara berurutan; sedangkan pada Apa-I adalah 54,4%, 38,9%, dan 6,7% untuk AA, 
Aa, dan aa. Frekuensi polimorfisme pada Bsm-I pada pasien HIV di Jawa Barat tergolong tinggi pada alel b (88,6%), dan berbanding terbalik pada dan Apa-I dengan alel A yaitu 73,91%. Penelitian lebih lanjut yang melibatkan 
individu kontrol diperlukan untuk mengetahui distribusi polimorfisme gen VDR pada populasi umum. Selain itu, 
studi kohort pada pasien HIV/AIDS diperlukan untuk menilai hubungan antara polimorfisme gen VDR terhadap progresivitas infeksi HIV.
Kata kunci: Apa-I, Bsm-I, polimorfisme, reseptor vitamin D, VDR
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Introduction
Acquired immune deficiency syndrome (AIDS), 
caused by human immunodeficiency virus (HIV) 
infection, is a syndrome associated with an increased risk of opportunistic infection due to an impaired immune system.1 The high prevalence 
of HIV/AIDS is still a vast global health issue, 
where Indonesia accounts for approximately 620.000 cases.2,3 
HIV infection is a chronic inflammatory 
disease characterized by Th1-like response. 
Therefore, the susceptibility to HIV infection 
and the rates of AIDS as a disease progression 
are associated with the host immune response.1 Vitamin D3 (1,25(OH)2D3) is essential in the immune system modulation.4 Vitamin D interacts 
with its specific intracellular vitamin D receptor 
and forms a complex Retinoid X Receptor (RXR) that further mediates vitamin D3 functions.5 The role of vitamin D3 - VDR complex in the immune system is to inhibit the maturation of dendritic 
cells as well as the proliferation of T lymphocyte in 
promoting proinflammatory cytokine synthesis and immune response. The inhibiting effect of vitamin D on the immune response appears to 
target Th1 cells by preventing their activation and lymphokine production. Furthermore, 
vitamin D triggers antimicrobial pathways in host cells and activates genes that enhance the immunity.6Vitamin D3 also plays a role in mineral metabolism, especially in regulating the calcium 
and skeletal homeostasis. Thus, the deficiency of vitamin D is related to skeletal diseases.7 
Non-skeletal diseases such as cancer, diabetes, cardiovascular diseases, and autoimmunity may 
also be influenced by the deficiency of vitamin D.8,9 Vitamin D deficiency is related to a higher risk of infection and poor prognosis of infectious diseases, such as tuberculosis and HIV.10
The underlying mechanisms to infection resistance and the variability observed in the rate of disease progression after infection are 
likely to be multifactorial, which may include the host genetic factor. VDR gene has several 
single nucleotide polymorphisms (SNPs) such as Bsm-I, Apa-I, and Taq-I that are found in 3’ 
untranslated region (UTR); Cdx2 and A-1012G in 5’ regulatory region, and Fok-I in the coding region.5 Bsm-I polymorphism or rs1544410 
is formed by substitution of adenine-guanine 
(A/G) and consists of B and b allele, whereas 
Apa-I or 7975232 is created by the substitution 
of guanine-thymine (G/T) and consists of A and a alleles. Interestingly, polymorphism in the 3’UTR 
VDR gene is associated with the mRNA stability of VDR that adjusts the expression of VDR and other polymorphism in VDR which also shows a 
modulation in vitamin D-VDR complex activity.5 
VDR gene, which encodes vitamin D receptor, has various polymorphisms and the variations at the VDR locus have been associated with the susceptibility and progression to several immune diseases.5 VDR polymorphism has shown to 
play a significant role in the susceptibility of other diseases, such as spinal7 and gynecological carcinoma.8 As for polymorphisms in VDR gene 
Fok-I, infected HIV patients carrying the Ff genotype has been considered prone to a faster 
progression to AIDS.11
The distribution of VDR polymorphisms 
differ across the global population. In Brazil, for 
example, the Bsm-I genotype BB, Bb, and bb are 
found in 16.5%, 50.4%, and 33.1%, respectively. 
However, in China, only BB (15.8%) and bb 
(84.2%) polymorphisms are observed.12,13  In Indonesia, the VDR polymorphism has been studied in several populations including, among others, in Batak ethnic in North Sumatera14 The difference of VDR polymorphisms in various 
populations has led this study to explore the distribution of VDR gene polymorphisms among 
HIV seropositive patients in West Java. The genotype carried by the HIV seropositive patients 
may serve as a predictor to consider whether an individual is prone to a faster progression to 
AIDS. 
Methods
This was a descriptive cross-sectional study on 
a total of 96 HIV/AIDS patients recruited from several cities in West Java in 2013. In brief, upon 
informed consent, genomic DNA was extracted according to the manufacturer’s procedure. Single nucleotide polymorphisms of the VDR 
gene at rs1544410, rs7975232, rs731236 and 
rs 2228570 or at the restriction site of Bsm-I, 
Apa-I, Taq-I, and Fok-I, respectively, were analyzed 
(Bead Xpress Readerâ, Illuminaâ) at the Molecular Biology Laboratory of Faculty of Medicine, 
Universitas Padjadjaran. This genotyping system 
machine is able to examine a total of 48 Single 
Nucleotide Polymorphisms (SNPs) of the four SNPs of the VDR gene examined. In brief, DNA 
was activated to bind to paramagnetic samples, 
and hybridization was followed according to the manufacturer’s protocol. Microbead code 
was then identified and the fluorescent signal 
was detected. The distribution of VDR gene 
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polymorphisms was visualized in a single dot that represented individual genotype. Data generated 
were then analyzed (GenomeStudioâ, Illuminaâ). 
The distribution of VDR gene polymorphisms 
was counted for the frequency and presented in the table.
This study was approved by the Health Research Ethics Committee of Faculty of Medicine, Universitas Padjadjaran Bandung through the issuance of the ethical clearance no. 948/UN6.KEP/EC/2018.
Results
In total, 96 HIV/AIDS patients were initially 
recruited. However, data on genotype could 
only be retrieved from 87 patients, consisting 
of 73 males (83.9%) and 14 females (16.1%). 
The mean age of the patients was 30.2 years old 
(SD±6.1). These patients were mostly (60.9%) 
injecting drug users (IDUs) and tuberculosis co-
infection was only found in a small proportion 
(4.7%) of the HIV/AIDS patients as depicted in 
Table 1. From the medical record collected, the 
mean of CD4 count was identified to be 318.02 
Table 1 Clinical Characteristics of HIV/AIDS 
 Patients in West Java
n %GenderMale 73 83.9Female 14 16.1Risk FactorIDU 53 60.9
Non-IDU 34 39.1
TB History
TB 4 4.6
No TB history 81 93.1Missing data 2 2.3Notes: IDU: injection drug use; TB: tuberculosis
Table 2 Distribution of Genotype and Allele of VDR Polymorphisms at Restriction Site of  Bsm-I 
 and Apa-I in HIV/AIDS Patients from West Java
VDR polymorphisms Genotype (%) Allele
Bsm-I BB Bb bb B B
2 (2.2) 17 (18.5) 73 (79.3) 11.4 88.6
Apa-I AA Aa aa A a
49 (54.4) 35 (38.9) 6 (6.7) 73.9 26.1
Figure 1 Distribution of rs1544410 Bsm-I VDR   
    Gene Polymorphism in West Java as   
                  Shown Using Illumina’s Genome   
   Studio®Every single dot represents individuals genotyped in oneplatefor 96 individuals. Pink area is designated as genotype BB, purple area as Bb, blue area as bb, respectively.
(SD±273.1). Since this was a cross-sectional 
study, the CD4 count could not be analyzed 
further for the correlation with the VDR 
polymorphisms result below.
The distribution of the VDR gene 
polymorphisms was visualized in a single dot that represented individual genotype as 
shown in Figures 1 and 2. Only Bsm-I and 
Apa-I polymorphisms were detected whereas polymorphisms of Taq-I and Fok-I were failed 
to be detected due to some technical error. The genotype of Bsm-I polymorphism was mostly bb 
(79.3%), with the most frequent b allele of 88.6%. 
Meanwhile, the genotype of Apa-I polymorphism 
was mostly AA (54.4%), with allele A as the most 
prevalent (73.9%) as depicted in Table 2.  
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Discussion Vitamin D receptor, encoded by the VDR gene, 
is a nuclear receptor (NR) superfamily that has an essential function in regulating the immune system in macrophages, dendritic cells, 
neutrophils, B cells, natural killer (NK) cells, and 
T lymphocyte.15 Studies on VDR polymorphisms 
have shown a significant role in susceptibility to HIV and an increasing role in the progression of 
HIV infection to AIDS, both in adult and pediatric patients.16,17 The VDR polymorphisms across the global population have different distributions. 
The present study in West Java has described the distribution of VDR gene polymorphisms at 
rs1544410 and rs7975232 or at the restriction site of Bsm-I and Apa-I, respectively. The result in Bsm-I polymorphism in Sundanese HIV 
infected patients has shown a high portion of 
b allele (79.3%), similar to the study on the 
general population of Batak people, which is another ethnic in Indonesia.14 The distribution of Bsm-I allele b is also in agreement with that 
of other Asian population13 but differs from the population from other continents in South 
America.12 It seems that the high portion of the 
b allele in the HIV-infected patients in this study 
also reflects the general population distribution 
and, thus, shows no difference. The important role of having a b allele needs to be further 
analyzed, for example to assess its association 
Figure 2  Distribution of rs7975232 Apa-I   
        VDR gene polymorphism in West 
    Java as Shown Using Illumina’s   
    Genome Studio®Every single dot represents individuals genotyped in one plate for 96 individuals. Pink area is designated as genotype 
AA, purple area as Aa, blue area as aa, respectively.
with the CD4 count.
Lymphocyte T CD4 has a gp120 glycoprotein 
structure that is associated with HIV initial 
infection. HIV binds with gp120 to begin its 
invasion and it will eventually damage the CD4 cells.18  CD4 cell death, caused by HIV, is associated 
with caspase-3-mediated apoptosis and caspase-
1-mediated pyroptosis.18 Thus, individuals 
with VDR polymorphisms may have lower CD4 counts due to the more rapid proliferation of the virus.15 Interestingly, a previous study of VDR 
SNPs related to HIV infection has shown that 
Bsm-I and Apa-I polymorphisms have produced 
lower IL-10 and had a decreased lymphocyte response.19 IL-10 function as an inhibitor for 
HIV-1 proliferation.In contrast, the Apa-I allele in Sundanese is 
mostly A (54.4%), which is equally distributed 
with allele a, and is similar to other countries 
in Asia, including in China13 and India.10 Again, the important result of having allele a needs further investigation. Furthermore, due to a technical problem in the laboratory, this study has failed to detect Taq-I and Fok-1 polymorphisms. Fok-1 polymorphism has been 
known to have a significant association with 
HIV/AIDS progression.11 CD4 cell count drops 
to below 200/uL faster in HIV infected patients 
with Fok-1 polymorphism or Ff carriers;11 therefore, the measurement of regular CD4 cell count is necessary to monitor the progression 
of HIV infection to AIDS when HIV-infection individual is carrying Ff genotype. Moreover, 
VDR polymorphisms also increase phagocytosis 
of macrophage towards M.tuberculosis that it 
may affect the progression of HIV-TB patients.10 
VDR gene polymorphisms may have impacted 
in vitamin D absorption among HIV/AIDS patients 
and may of great interest to explore further. Vitamin D supplementation in patients infected 
with HIV can improve antibacterial immunity.20 Vitamin D is able to inhibit the proliferation of 
T lymphocyte. Therefore, by giving HIV/AIDS patients vitamin D supplementation, a protective effect may be gained due to decreasing activated immune system and HIV target cells.21
This study has encountered several limitations 
because it was only performed among HIV/AIDS patients that the comparison in the distribution of VDR polymorphism, especially Bsm-I and Apa-I, in the general population cannot be observed 
and cannot be compared with healthy controls. 
Therefore, studies involving healthy controls in the same area are necessary. Furthermore, a cohort study is considered a better study design 
to explore the progression of HIV infection to 
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AIDS or to assess the fall of CD4 cell count as an effect of VDR polymorphisms.
To conclude, the frequency of VDR 
polymorphisms among HIV-infected patients in West Java is considered high for b allele of 
Bsm-I (88.6%) and a allele of Apa-I is common 
(26.1%). VDR polymorphisms among HIV-infected patients may have a predictor value in the progression of HIV infection. 
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